2
Orphan Designations
0
FDA Approvals
6
Rare Diseases
0
News Articles
| Disease | Drug(s) | Designation | Approved |
|---|---|---|---|
| acute graft versus host disease | enriched CD34+ hematopoietic stem and progenitor cells / highly purified CD34-CD25+CD4+CD127-regulatory T cells / conventional T cells (Orca-T) | Orphan Designation | - |
| chronic graft versus host disease | enriched CD34+ hematopoietic stem and progenitor cells / highly purified CD34-CD25+CD4+CD127-regulatory T cells / conventional T cells (Orca-T) | Orphan Designation | - |
| congenital lethal erythroderma | Enriched CD34+ hematopoietic stem and progenitor cells/highly puridied CD34-CD25+CD4+CD127-regulatory T cells/conventional T cells | Orphan Designation | - |
| graft versus host disease | enriched CD34+ hematopoietic stem and progenitor cells / highly purified CD34-CD25+CD4+CD127-regulatory T cells / conventional T cells (Orca-T) | Orphan Designation | - |
| major depressive disorder | Enriched CD34+ hematopoietic stem and progenitor cells/highly puridied CD34-CD25+CD4+CD127-regulatory T cells/conventional T cells | Orphan Designation | - |
| post-treatment Lyme disease syndrome | Enriched CD34+ hematopoietic stem and progenitor cells/highly puridied CD34-CD25+CD4+CD127-regulatory T cells/conventional T cells | Orphan Designation | - |